News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Amir Horowitz: Treatment strategies and management of BCG-unresponsive NMIBC
Photo of Amir Horowitz taken from labs.icahn.mssm.edu
Aug 27, 2024, 22:03

Amir Horowitz: Treatment strategies and management of BCG-unresponsive NMIBC

Amir Horowitz shared on X:

“Honored to play small role in shaping guidelines for treatment strategies and management of BCG-unresponsive NMIBC under the brilliant efforts of Ashish M. Kamat and IBCG.”

Source: Amir Horowitz/X

Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection.

Authors: Roger Li, Patrick J. Hensley, Shilpa Gupta, Hikmat Al-Ahmadie, Marko Babjuk, Peter C. Black, Maurizio Brausi, Kelly K. Bree, Mario I. Fernández, Charles C. Guo, Amir Horowitz, Donald L. Lamm, Seth P. Lerner, Yair Lotan, Paramananthan Mariappan, David McConkey, Laura S. Mertens, Carmen Mir, Jeffrey S. Ross, Michael O’Donnell, and Ashish M. Kamat.

Amir Horowitz

Amir Horowitz, PhD is an Assistant Professor of Oncological Sciences and a member of the Precision Immunology Institute and the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. He pioneered the first studies of human NK cells by mass cytometry (CyTOFTM).

Amir Horowitz Ashish M. Kamat bladder cancer cancer Carmen Mir Charles C. Guo David McConkey Donald L. Lamm Hikmat Al-Ahmadie IBCG Jeffrey S. Ross Kelly K. Bree Laura S. Mertens Mario I. Fernández Marko Babjuk Maurizio Brausi Michael O’Donnell NMIBC Non-muscle-invasive Bladder Cancer OncoDaily Oncology Paramananthan Mariappan Patrick J. Hensley Peter C. Black Roger Li Seth P. Lerner Shilpa Gupta Yair Lotan
Special Coverage
Blog
Apr 19, 2025, 17:53
Cancer Nutrition Tips: Pink Africa Foundation Highlights Healing Benefits
Blog
Apr 19, 2025, 17:21
Exploring the integration of patient-reported outcome measures in clinical practice
Blog
Apr 19, 2025, 17:17
Join our Networks and Working Groups to learn, network and grow - SIOP
Blog
Apr 19, 2025, 17:14
Re-irradiation revolution: Maximising technical advances in imaging, biology and dose evaluation at ESTRO 2025
Blog
Apr 19, 2025, 17:02
New whitepaper on navigation services and reimbursement success - Florida Cancer Specialists and Research Institute
Blog
Apr 19, 2025, 17:01
Chiara Mercinelli: Honored to have been selected for the ASCO 2025 Merit Award
Blog
Apr 19, 2025, 16:48
How EveryGrant helps organizations build impactful grant programs - Conquer Cancer, the ASCO Foundation
Blog
Apr 19, 2025, 16:44
Agenus to Reveal Phase 1 HCC Immunotherapy Data at AACR 2025
Blog
Apr 19, 2025, 16:36
Bilal Awad: Knowledge, attitudes, and self-efficacy regarding palliative care among Palestinian nurses in intensive care units
Blog
Apr 19, 2025, 16:23
Toufic Kachaamy: Thrilled to give two talks on cancer ablation at DDW2025
Blog
Apr 19, 2025, 16:23
Elvina Almuradova: Olaparib improved ORR and PFS in BRCA-mutated PSR ovarian cancer, but no OS benefit
Blog
Apr 19, 2025, 16:12
Cristian Massacesi: Visiting our AstraZeneca team in Germany to talk oncology ambitions